Next-Generation Antibody Engineering: Beyond Monoclonals

toegevoegd een audio Health

2025-12-26 08:56:26 -

What is the state of antibody innovation in the oncology market? While monoclonal antibodies (mAbs) have dominated the market for decades, they face limitations in solid tumor penetration and specific targeting. Protein engineering is addressing these gaps through the design of bispecific and multispecific antibodies. These molecules can simultaneously bind to two or more different epitopes,...

0 Reacties 0 aandelen 3 Views 0 voorbeeld